Myricetin-loaded SBA-15 silica nanoparticles for enhanced management of pyrexia, pain, and inflammation through modulation of MAPK/NF-κB and COX-2/PGE-2 pathways: Evidence from the biochemical, histological, and metabolomic analysis

Update your browser to view ScienceDirect.

Request details:

Request ID: 8d3ba9e4d9be67ac-LAX
IP: 101.37.83.79
UTC time: 2024-10-16T23:00:11+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4